Hjemmelegene AS
Score · fiscal year 2025
22of 100
How to read this: the company is ahead of 8 % of companies in the Morning class Small in the same sector in 2025. What does this mean?
Rank in the Morning class Small: 310 of 336 · What are Morning company classes?
Place in the whole sector: 1,856 of 2,037 · Helse og omsorg
Profile
Beaver · Builder
Lower profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 4 and solidity 9 out of 100 among companies in the Morning class Small in the same sector in 2025. Methodology
Against the sector
Hjemmelegene AS is 29 points below the median for companies in the Morning class Small in the same sector in 2025.
Median score 51 among 336 companies.
Against companies in the Morning class Small in the same sector in 2025: operating margin −11.3% (median 5.0%) and equity ratio 2.4% (median 39.8%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 26 MNOK | 21 MNOK |
| Operating margin | −11.3% | 5.0% |
| Profit margin | −11.5% | 5.1% |
| Return on assets | −24.0% | 9.4% |
| Equity ratio | 2.4% | 39.8% |
| Debt-to-equity | 41.02 | 1.22 |
| Current ratio | 0.88 | 1.47 |
| Revenue growth | 15.9% | 4.9% |
| Revenue per employee | 0.84 MNOK | 1.03 MNOK |
The median and “ahead of” refer to companies in the Morning class Small in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 22, Hjemmelegene AS does better than 8% of companies in the Morning class Small in the same sector (336 companies) in 2025.
Score 2023–2025
- Hjemmelegene AS
- Median: companies in the Morning class Small in the same sector
Hjemmelegene AS has a score of 22 for 2025, rank 1,856 of 2,037 in the sector.
Strongest: Growth: percentile 77 against peers, revenue growth 15.9% against a median of 4.9%.
Weakest: Profitability: percentile 4 against peers, operating margin −11.3% against a median of 5.0%. Solidity: percentile 9 against peers, equity ratio 2.4% against a median of 39.8%.
Worth a closer look
- The equity ratio is very low. Could the company absorb a bad year, and does it need more equity? Based on: equity ratio 2.4% (median 39.8%).
- Consider strengthening liquidity: current liabilities are 1.1 times current assets. Based on: current ratio 0.88 (median 1.47).
- The company made a loss before tax. Are these one-off items or a pattern? Based on: profit margin −11.5% (median 5.1%).
- What lies behind weak profitability, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
Hjemmelegene AS had an operating margin of −11.3% and an equity ratio of 2.4% in 2025, and ranks 1,856 of 2,037 in Helse og omsorg.
From 2024 to 2025: the operating margin rose from −42.9% to −11.3% and the equity ratio fell from 38.9% to 2.4%.
This text is generated automatically from the 2025 accounts.
Three simple methods
One method gives a figure: 0 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | not meaningful |
| EV/EBIT | 8.0 | not meaningful |
| P/B | 1.0 | 0 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
The equity ratio is very low. Could the company absorb a bad year, and does it need more equity?
Based on: Equity ratio 2.4% (median 39.8%).
- watch
Consider strengthening liquidity: current liabilities are 1.1 times current assets.
Based on: Current ratio 0.88 (median 1.47).
- watch
The company made a loss before tax. Are these one-off items or a pattern?
Based on: Profit margin −11.5% (median 5.1%).
- watch
The operating margin is lower than at three in four companies in the sector. Where do costs differ from competitors?
Based on: Operating margin −11.3% (median 5.0%).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.7% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of −10.4%. Based on the 6 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 4 | weight 30% |
|---|---|---|
| Solidity | 9 | weight 25% |
| Liquidity | 18 | weight 15% |
| Growth | 77 | weight 15% |
| Consistency | 26 | weight 15% |
Durability: 16 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Hjemmelegene AS?
The operating margin was −11.3% in 2025, against a median of 5.0% among companies in the Morning class Small in the same sector. Return on assets was −24.0%. The company made a loss before tax.
How solid is Hjemmelegene AS?
The equity ratio was 2.4% in 2025 (median 39.8%). Debt-to-equity was 41.02 (median 1.22).
What is the liquidity of Hjemmelegene AS like?
The current ratio was 0.88 in 2025 (median 1.47). Current assets did not cover current liabilities.
How does Hjemmelegene AS compare in Helse og omsorg?
Hjemmelegene AS ranks 1,856 of 2,037 in Helse og omsorg for 2025. Among companies in the Morning class Small it is number 310 of 336. Revenue changed by 15.9% from the year before.
Public contracts
- Contracts awarded since 2024
- 0
- Total awarded value since 2024
- value not stated
| Date | Buyer | Notice | Value |
|---|---|---|---|
| 16 October 2023 | NTNU | Influensavaksine | 3.2 MNOK |
Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.
Source: Doffin (DFØ), fetched 27 October 2026. Winners are matched on organisation number.
Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0
From the Central Coordinating Register
- Org. no.
- 918605878
- Legal form
- AS
- Sector
- Helse og omsorg (86.210)
- Morning company class
- Small
- Employees
- 31 registered 10 September 2026
- Founded
- 1 February 2017 9 years in operation
- Share capital
- 1.28 MNOK
- Business address
- Dronning Eufemias gate 16, 0191 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
- Website
- hjemmelegene.no
- LEI
- 636700GEFOKON4BSLY06 renews 26 October 2027
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 31 October 2026. Only names are shown.
- Parent company
- Parent not reported
Source: GLEIF (Global Legal Entity Identifier Foundation), fetched 31 October 2026. The parent is the one the company itself reported to GLEIF.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 30 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 1 | 26 | 22 | |
| Rank | 1,951 | 1,732 | 1,856 | |
| Operating margin | −92.8% | −42.9% | −11.3% | |
| Return on assets | −136.2% | −112.7% | −24.0% | |
| Equity ratio | −84.3% | 38.9% | 2.4% | |
| Current ratio | 0.34 | 1.44 | 0.88 | |
| Revenue growth | – | −2.6% | 15.9% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 23.2 MNOK | 22.6 MNOK | 26.2 MNOK |
| Operating profit | −21.5 MNOK | −9.7 MNOK | −3.0 MNOK |
| Profit before tax | −22.5 MNOK | −10.6 MNOK | −3.0 MNOK |
| Net profit | −22.5 MNOK | −10.6 MNOK | −3.0 MNOK |
| Financial expenses | 1.2 MNOK | 1.0 MNOK | 0.1 MNOK |
| Total assets | 15.6 MNOK | 8.5 MNOK | 12.2 MNOK |
| Current assets | 9.6 MNOK | 6.2 MNOK | 9.7 MNOK |
| Equity | −13.2 MNOK | 3.3 MNOK | 0.3 MNOK |
| Retained earnings | −104.5 MNOK | −115.1 MNOK | −118.1 MNOK |
| Total liabilities | 28.8 MNOK | 5.2 MNOK | 11.9 MNOK |
| Current liabilities | 27.8 MNOK | 4.3 MNOK | 11.0 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 30 October 2026, accounts id 7243650.
Further
Similar companies
- Grünerløkkas Hus Tannlegesenter AS index 23, rank 1,843 · compare
- Novita Omsorg AS index 23, rank 1,845 · compare
- Blid AS index 22, rank 1,848 · compare
- Oris Dental Holding AS index 22, rank 1,857 · compare
- PARMANN & Hagen AS index 21, rank 1,862 · compare